Related Experiment Video
Updated: Jul 11, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
High Risk Acetaminophen Ingestion in a Nine-Month-Old Requiring Hemodialysis: A Case Report
Camille Mero1, Raven Haan1, Sandra Al Tamimi2
1Herman and Walter Samuelson Children's Hospital, Pediatric Residency.
Insights
High-risk acetaminophen overdose in infants requires prompt treatment with N-acetylcysteine (NAC) and extracorporeal toxin removal. This case highlights successful multimodal management, including hemodialysis and continuous renal replacement therapy, preventing liver failure.
Area of Science:
- Pediatric Toxicology
- Critical Care Medicine
- Pharmacology
Background:
- Acetaminophen (APAP) overdose in infants is rare but can lead to rapid metabolic decline and mitochondrial dysfunction.
- Limited pediatric-specific management guidelines exist for severe APAP poisoning.
- Early recognition and intervention are critical for survival in infant APAP overdose.
Purpose of the Study:
- To present a case of successful multimodal management of high-risk acetaminophen poisoning in an infant.
- To highlight practical considerations for N-acetylcysteine (NAC) dosing during extracorporeal toxin removal.
- To underscore public health concerns related to medication accessibility and formulation in pediatric ingestions.
Main Methods:
- A 9-month-old infant ingested a large dose of acetaminophen, presenting with altered mental status, severe metabolic acidosis, coagulopathy, and respiratory failure.
- Treatment involved high-dose N-acetylcysteine (NAC), fomepizole, intermittent hemodialysis (HD), and continuous renal replacement therapy (CRRT).
- Management included aggressive phosphorus repletion and prolonged mechanical ventilation.
Main Results:
- The infant survived without progression to acute liver failure.
- Extracorporeal toxin removal (HD and CRRT) was a key component of the successful treatment.
- NAC dose adjustments were necessary during renal replacement therapy.
Conclusions:
- Multimodal management, including extracorporeal toxin removal and adjunctive therapies, can be effective for severe infant acetaminophen poisoning.
- Practical challenges in NAC dosing during renal replacement therapy were addressed.
- Public health strategies, such as limiting acetaminophen quantities and discouraging child-attractive formulations, are needed to prevent severe ingestions.
Background:
High-risk acetaminophen (APAP) overdose in infants is rare but may result in rapid metabolic deterioration due to early mitochondrial dysfunction. Prompt recognition and aggressive intervention are essential for survival, yet pediatric-specific management strategies remain limited in the literature.
Case Presentation:
A previously healthy 9-month-old boy ingested an estimated 25 g of acetaminophen (∼2700 mg/kg by history) following an exploratory ingestion. Within 4 hours, he developed an altered mental status, severe anion-gap metabolic acidosis with lactic acidosis, early coagulopathy, and respiratory failure. He was diagnosed with high-risk acetaminophen poisoning complicated by adenovirus-associated acute respiratory distress syndrome (ARDS).
Management And Outcome:
Treatment included high-dose N-acetylcysteine (NAC), adjunctive fomepizole, 2 sessions of intermittent hemodialysis (HD), followed by 16 hours of continuous renal replacement therapy (CRRT). Management also required aggressive phosphorus repletion and prolonged mechanical ventilation. The patient was extubated on day 17 and discharged on day 35 without progression to acute liver failure.
Conclusion:
This case demonstrates successful multimodal management of high-risk acetaminophen poisoning in an infant using extracorporeal toxin removal and adjunctive therapies. It highlights practical considerations for NAC dose adjustment during HD and CRRT and underscores important public health concerns regarding the accessibility and formulation of potentially lethal medications. Regulatory strategies limiting acetaminophen quantities per container and discouraging formulations attractive to young children may reduce the risk of severe exploratory ingestions.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care

